Delivery Order SPE2DB22D3501-SPE2DB24FTY11

Award Date 12/21/23
Potential Completion Date 12/22/23
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,245.43 firm fixed price delivery order is for the supply of 30-count tablets of the pharmaceutical Entecavir 0.5 mg. The contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. This delivery order is part of a larger indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of Entecavir 0.5 mg tablets, valued at $3,000.82 with a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received numerous prior...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,062.15 contract is for the delivery of Entecavir 0.5 milligram tablets to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
This federal contract award was issued by the Medical Supply Chain unit of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $10,669.80 firm fixed-price delivery order is for the supply of 4,565,297 units of Entecavir 0.5 mg tablets. The contract has a final delivery date of July 31, 2024 and does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous indefinite delivery contracts by...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,758.86 Firm Fixed Price Delivery Order is for the supply of 4564950562 - Entecavir 0.5 mg Tablet 30s, with a period of performance through June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,810.25 contract is for the delivery of Entecavir 0.5 mg tablets to support DLA Troop Support Medical operations. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals and medical supplies to the Department of Defense under similar firm...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,764.06 firm fixed-price delivery order is for the supply of Entecavir 0.5 mg Tablets, with a period of performance through November 1, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $10,436.04 firm-fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets in 30-count packages. The contract has an ultimate completion date of October 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $9,458.03 firm fixed-price delivery order is for the supply of 4,565,749,496 tablets of the medication Entecavir 0.5 mg. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous contracts by the DLA and other federal agencies to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,464.29 firm fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets, with a completion date of November 15, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FTY11
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,976.27 firm fixed price delivery order is for the supply of Entecavir 0.5 mg tablets to support DLA Troop Support Medical's provision of pharmaceuticals and critical care supplies for military treatment programs and facilities. The contract has a completion date of December 22, 2023 and was awarded on December 21, 2023. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp has a history of providing a range of pharmaceutical and medical products and services to U.S. government agencies, primarily the Department of Defense, through similar firm fixed price delivery orders awarded by DLA.

Generated 3/21/24, 9:41 AM